PRX003 for Psoriasis and Other Inflammatory Diseases. Prothena Corporation plc is a late-stage clinical. Biotechnology company focused on the discovery,. Development and commercialization of novel. Protein immunotherapy programs for the. Potential treatment of diseases that. Involve amyloid or cell adhesion. Our Phase 3 VITAL Study website is now online.

Winner of the certified termination competition 2007. New PhD and postdoc opportunities! Of the Quotient project. Proof of the termination criterion based on dependency graph cycles.

Markus Rehm the Olympic champion from Protheofit. Markus Rehm the Olympic champion from Protheofit. He is responsible for the technical assessment of your prosthesis. We bring drive to your life. We bring drive to your life.

We help you to create a new business applications that capitalize on modern technologies and tools to increase your competitive advantage. No need to spend your IT budget on sending your current staff to extensive IT training and seminars, and no need to hire professionals by spending more time on recruitment.

ProThera has developed a novel process to purify Inter-alpha Inhibitor Proteins from source materal, and has conducted ground-breaking research into the usage of IAIP to fight systemic inflammation across multiple indication areas. President and Chief Business Officer. 2015 ProThera Biologics, Inc.